Abstract
Background
Reduced health-related quality of life (HRQoL) is a common complaint in patients suffering from pituitary tumors. Although successful tumor treatment has been reported to lead to an improvement in perceived HRQoL, the temporal gradient at which these improvements occur has not been fully addressed.
Methods
Using three validated health-related questionnaires (SF-36, SCL-90-R, QLS-H), we assessed HRQoL in 106 adult patients harboring pituitary tumors (mean age 48.0 ± 16.0 years) before as well as 3 and 12 months after initiation of treatment. The AcroQoL questionnaire was additionally applied in acromegalic patients.
Results
There was a significant improvement in all but one scale (role-physical) of the SF-36 questionnaire and all but two scales (interpersonal sensitivity, paranoid ideation) of the SCL-90-R, the QLS-H score and the AcroQoL subscales within 3 months after surgical treatment. The trend to amelioration continued at the 12 month re-assessment, but did not reach statistical significance. Linear regression analyses revealed that younger age and male gender favor a more distinct improvement of HRQoL after treatment.
Conclusions
HRQoL is considerably reduced before treatment for pituitary disease. Improvement is an early postoperative phenomenon and occurs within 3 months after treatment. Men and younger patients are more likely to improve within this time span.
Similar content being viewed by others
Abbreviations
- AC:
-
Acromegaly
- AcroQoL:
-
Acromegaly Quality of Life Questionnaire
- CD:
-
Cushing’s disease
- fT3:
-
Free tri-iodothyronine
- fT4:
-
Free thyroxine
- SF-36:
-
Short Form-36
- SCL-90-R:
-
Symptom Checklist 90-Revised
- HRQoL:
-
Health related quality of life
- QLS-H:
-
Questions on Life Satisfaction-Hypopituitarism
References
Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369–5376
Blum A, Maser E (2003) Enzymology and molecular biology of glucocorticoid metabolism in humans. Prog Nucleic Acid Res Mol Biol 75:173–216
Bullinger M, Kirchberger I (1998) SF-36. Fragebogen zum Gesundheitszustand. Handanweisung. Hogrefe, Göttingen
Burman P, Deijen JB (1998) Quality of life and cognitive function in patients with pituitary insufficiency. Psychother Psychosom 67:154–167, Review
Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J (1991) The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68:860–866
Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:3364–3369
Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912–919
Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV (1986) Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64:713–719
Feldkamp J, Santen R, Harms E, Aulich A, Mödder U, Scherbaum WA (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol [Oxf] 51:109–113
Flitsch J, Spitzner S, Lüdecke DK (2000) Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 108:480–485
Franke G (1995) Die Symptom-Checkliste von Derogatis - Deutsche Version—[SCL-90-R]. Manual. Beltz Test GmbH, Göttingen
Furman K, Ezzat S (1998) Psychological features of acromegaly. Psychother Psychosom 67:147–153, Review
Herschbach P, Henrich G, Strasburger CJ, Feldmeier H, Marín F, Attanasio AM, Blum WF (2001) Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. Eur J Endocrinol 145:255–265
Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81–87
Kauppinen-Mäkelin R, Sane T, Sintonen H, Markkanen H, Välimäki MJ, Löyttyniemi E, Niskanen L, Reunanen A, Stenman UH (2006) Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91:3891–3896
Kelly WF, Kelly MJ, Faragher B (1996) A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol [Oxf] 45:715–720
Korali Z, Wittchen HU, Pfister H, Höfler M, Oefelein W, Stalla GK (2003) Are patients with pituitary adenomas at an increased risk of mental disorders? Acta Psychiatr Scand 107:60–68
Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447–453
Marazuela M, Astigarraga B, Vicente A, Estrada J, Cuerda C, García-Uría J, Lucas T (1994) Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Investig 17:703–707
McComb DJ, Ryan N, Horvath E, Kovacs K (1983) Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 107:488–491
Nomikos P, Ladar C, Fahlbusch R, Buchfelder M (2004) Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas – a study on 721 patients. Acta Neurochir (Wien) 146:27–35, Erratum in: Acta Neurochir [Wien] 2004, 146:433
Paisley AN, Trainer PJ (2003) Medical treatment in acromegaly. Curr Opin Pharmacol 3:672–677
Pantanetti P, Sonino N, Arnaldi G, Boscaro M (2002) Self image and quality of life in acromegaly. Pituitary 5:17–19, Review
Rosilio M, Blum WF, Edwards DJ, Shavrikova EP, Valle D, Lamberts SW, Erfurth EM, Webb SM, Ross RJ, Chihara K, Henrich G, Herschbach P, Attanasio AF (2004) Long-term improvement of quality of life during growth hormone [GH] replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism [QLS-H]. J Clin Endocrinol Metab 89:1684–1693
Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life [QOL] in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337–3341
Sardella C, Lombardi M, Rossi G, Cosci C, Brogioni S, Scattina I, Webb SM, Gasperi M, Martino E, Bogazzi F (2010) Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J Endocrinol Investig 33:20–25
van Aken MO, Lamberts SW (2005) Diagnosis and treatment of hypopituitarism: an update. Pituitary 8:183–191, Review
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short form health survey [SF-36]. Conceptual framework and item selection. Med Care 30:473–474
Webb SM, Badia X (2007) Quality of life in growth hormone deficiency and acromegaly. Endocrinol Metab Clin North Am 36:221–232, Review
Webb SM, Badia X, Surinach NL, Spanish AcroQoL Study Group (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155:269–277
Webb SM (2006) Quality of life in acromegaly. Neuroendocrinology 83:224–229
Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly Quality of Life Questionnaire [ACROQOL] a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol [Oxf] 57:251–258
Wichers-Rother M, Hoven S, Kristof RA, Bliesener N, Stoffel-Wagner B (2004) Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp Clin Endocrinol Diabetes 112:323–327
Yanovski JA, Cutler GB Jr (1994) Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin N Am 23:487–509, Review
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Comment
Well-being in pituitary surgery patients is a very interesting area. This nice study looks at outcomes in well being at time of surgery, at three months, and at 12 months from surgery. As expected, most improve significantly to three months except Cushing's patients (who will still be feeling unwell) and not much more until the 12-month review (which was not significant, although I would guess this was sample-size related).
The good thing is that most of our patients improve what ever!
Michael Powell
London, UK
Rights and permissions
About this article
Cite this article
Milian, M., Honegger, J., Gerlach, C. et al. Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors—a longitudinal study of 106 patients. Acta Neurochir 155, 1637–1645 (2013). https://doi.org/10.1007/s00701-013-1809-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-013-1809-7